Premium
Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia
Author(s) -
Weller M.,
Stevens A.,
Sommer N.,
Schabet M.,
Wiethölter H.
Publication year - 1992
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1992.tb05053.x
Subject(s) - cerebrospinal fluid , pathology , medicine , lymphoma , differential diagnosis , bone marrow , immunology
Cerebrospinal fluid (CSF) and serum samples of 20 patients with central nervous system manifestations of hematological malignancies including primary cerebral lymphoma (n = 5) and disseminated non‐Hodgkin lymphoma (n = 7) were examined for albumin, IgG, IgM, fibronectin, β 2 ‐microglobulin, interleukin‐6, soluble interleukin‐2 receptor, tumor necrosis factor alpha, and oligoclonal immunoglobulin bands. Although a broad range of abnormalities were detected, no reliable CSF parameter for the diagnosis of leptomeningeal spread from hematological neoplasias could be identified. An analysis of 61 repeat lumbar punctures added little to the findings of the first CSF examinations. Currently, immunochemical studies of CSF cell surface markers and early biopsy have probably more clinical value than the determination of the humoral CSF parameters included in this study. However, analysis of cytokine synthesis by single CSF cells using molecular biology techniques may improve the differential diagnosis of hematological neoplasia of the brain and spinal cord in the future.